Criteria for identifying radiologists with acceptable screening mammography interpretive performance on basis of multiple performance measures

AJR. American Journal of Roentgenology
Diana L MigliorettiPatricia A Carney

Abstract

Using a combination of performance measures, we updated previously proposed criteria for identifying physicians whose performance interpreting screening mammography may indicate suboptimal interpretation skills. In this study, six expert breast imagers used a method based on the Angoff approach to update criteria for acceptable mammography performance on the basis of two sets of combined performance measures: set 1, sensitivity and specificity for facilities with complete capture of false-negative cancers; and set 2, cancer detection rate (CDR), recall rate, and positive predictive value of a recall (PPV1) for facilities that cannot capture false-negative cancers but have reliable cancer follow-up information for positive mammography results. Decisions were informed by normative data from the Breast Cancer Surveillance Consortium (BCSC). Updated combined ranges for acceptable sensitivity and specificity of screening mammography are sensitivity≥80% and specificity≥85% or sensitivity 75-79% and specificity 88-97%. Updated ranges for CDR, recall rate, and PPV1 are: CDR≥6 per 1000, recall rate 3-20%, and any PPV1; CDR 4-6 per 1000, recall rate 3-15%, and PPV1≥3%; or CDR 2.5-4.0 per 1000, recall rate 5-12%, and PPV1 3-8%. Using the ...Continue Reading

References

Oct 6, 1997·AJR. American Journal of Roentgenology·R Ballard-BarbashL G Kessler
Dec 5, 2000·Annals of Internal Medicine·K KerlikowskeR Ballard-Barbash
Aug 21, 2002·Annals of Internal Medicine·Linda L HumphreyHarold C Sox
Apr 24, 2003·Medical Education·John J Norcini
Nov 25, 2003·Evaluation & the Health Professions·Gregg TalenteJohn F Wilson
Sep 20, 2005·The New England Journal of Medicine·Etta D PisanoUNKNOWN Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group
Mar 30, 2007·CA: a Cancer Journal for Clinicians·Debbie SaslowUNKNOWN American Cancer Society Breast Cancer Advisory Group
Nov 19, 2009·Annals of Internal Medicine·Heidi D NelsonUNKNOWN U.S. Preventive Services Task Force
Oct 19, 2011·Annals of Internal Medicine·Karla KerlikowskeUNKNOWN Breast Cancer Surveillance Consortium
Jan 9, 2013·Radiology·Patricia A CarneyDiana L Miglioretti
Dec 29, 2013·American Journal of Pharmaceutical Education·Gregory L Alston, Wesley R Haltom

❮ Previous
Next ❯

Citations

Jan 23, 2016·AJR. American Journal of Roentgenology·Chloe M Chhor, Cecilia L Mercado
Oct 23, 2015·AJR. American Journal of Roentgenology·Jay R Parikh, Wei T Yang
Jul 11, 2018·The British Journal of Radiology·Delgermaa DemchigPatrick C Brennan
Oct 19, 2017·AJR. American Journal of Roentgenology·Cindy S LeeDebra L Monticciolo
Dec 10, 2020·AJR. American Journal of Roentgenology·Mohammad EghtedariHaydee Ojeda-Fournier
Jun 3, 2021·International Journal of Environmental Research and Public Health·Giulia BicchieraiJacopo Nori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.